AbCellera (ABCL) Misses Q2 EPS by 8c

AbCellera (NASDAQ: ABCL) reported Q2 EPS of $0.03, $0.08 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $27.6 million versus the consensus estimate of $87.32 million.

For earnings history and earnings-related data on AbCellera (ABCL) click here.

You May Also Be Interested In

• AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
• Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
• Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance